ALFA Finder
11:49 IST
NSE
Earnings Call
NGL Fine - Chem Earnings Call Transcript: Key Takeaways
NGL delivered strong volume-led revenue growth but faces margin pressure from new Tarapur facility costs.
NGL Fine - Chem Ltd
- Share price
- ₹3,030.10
- Market cap
- ₹1,872 Cr
- Revenue (annual)
- ₹500.9 Cr
- Net profit (annual)
- ₹48.13 Cr
- P/E (TTM)
- 29.3×Sector 43.8×
- Promoter holding
- 72.49%+0.00% QoQ
- FII holding
- 0.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Other Announcement 5Financial Results 4Board Meeting Date 3Legal & Regulatory 2Board Meeting Outcome 2Annual Report 2Annual General Meeting 2Promoter Buying (Off-Market) 1Production Started 1Dividend 1
Time
6 announcements with these filters
22:37 IST
BSE
Earnings Call
NGL Fine - Chem Investor Presentation: Key Takeaways
Q2FY27 revenue ₹158.71 Cr (+31.97% YoY), EBITDA ₹28.06 Cr (17.68% margin), PAT ₹16.25 Cr (+68.74% YoY). Phase II plant commissioned; regulatory build-out ongoing.
14:52 IST
BSE
Earnings Call
NGL Fine - Chem Investor Presentation: Key Takeaways
NGL Fine-Chem reported robust Q1FY27 performance with Revenue of ₹139.16 Cr (up 33.6% YoY) and PAT of ₹18.40 Cr (up 99.1% YoY). Growth was driven by sustained demand and forex gains.
22:49 IST
BSE
Earnings Call
NGL Fine - Chem Earnings Call: Key Takeaways
NGL Fine-Chem reported strong Q4 FY26 results with 57% YoY revenue growth and significant margin expansion. Management focuses on capacity expansion and penetrating regulated markets (Europe/US).
17:38 IST
BSE
Earnings Call
NGL Fine - Chem Earnings Call: Key Takeaways
NGL Fine Chem reports a strong recovery in FY26, driven by higher volumes and expanded intermediate production. However, management remains cautious about returning to peak historical margins due to persistent global competition and cost pressures.
22:45 IST
BSE
Earnings Call
NGL Fine - Chem Earnings Call: Key Takeaways
NGL Fine-Chem delivered strong FY26 performance with revenue up 36% to ₹501cr and PAT up 127% to ₹48cr, driven by volume growth in the animal health segment.